Plain-English translation of NCT04638790 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing three different chemotherapy strategies for people newly diagnosed with classical Hodgkin lymphoma. The treatment approach depends on your cancer stage and whether it has certain risk factors. The study uses imaging scans to track how well the medication is working and adjusts your treatment plan accordingly — some patients may receive additional chemotherapy, radiation, or a stem cell transplant depending on their response.
Doctors want to find the best way to treat Hodgkin lymphoma at different stages using the most effective combination of chemotherapy, radiation, and potentially stem cell transplants. This trial compares different approaches to see which gives patients the best chance of recovery with manageable side effects.
You likely qualify if…
You likely don't qualify if…
You will receive chemotherapy treatment in cycles over several months, with imaging scans (PET-CT) performed between treatment cycles to monitor how well the cancer is responding. Based on your scan results, your doctor may adjust your treatment plan — you might continue with the same chemotherapy, add radiation therapy, receive additional chemotherapy cycles, or move to a stem cell transplant if needed. You will have regular clinic visits for blood tests, physical exams, and heart monitoring throughout your treatment.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
India
Russia